Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
about
Antipsychotic medication for early episode schizophreniaOlanzapine for schizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.Placebo response in antipsychotic clinical trials: a meta-analysis.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design featuresPredictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in JapanAcute psychiatric inpatient care: a cross-cultural comparison between two hospitals in Germany and Japan.Olanzapine in Chinese treatment-resistant patients with schizophrenia: an open-label, prospective trial.Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant.Treatment of schizophrenia: implications derived from an intercultural hospital comparison between Germany and Japan.Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia.
P2860
Q24236683-0C7FB15D-2902-4B58-BDD6-0DB456F28956Q24244031-7EDAEC6C-364C-4C33-BD82-B7B51A488953Q33223628-2BA8BC50-4233-428A-9A85-4608E56ECA8AQ33713759-815E5D48-22B9-43E1-B556-35D18859EA10Q33738740-2E1C2994-2EB3-4B69-8883-5B9CD9EAACBFQ34443837-229C5644-72EB-4E2F-9BA2-8EE0CFBACA91Q34640811-C3495CCD-D951-4FE4-9C2F-6AB50721793EQ37227479-1FE77156-4645-4BA9-92E0-5B6B701F472EQ40427460-037CD166-9B33-4D7B-805B-F81ED286407CQ43442718-AE88B28A-AA06-4A4B-8530-A7A4A9688FD5Q44570187-C50EC9A4-56DA-497C-A133-5812771E1AB5Q46915026-A3ACA1A5-85B1-43A0-8346-BA931D32F220Q47277353-8D20FDBE-30F8-45B6-BDB2-D7C9405D50F8Q51917811-7CB2E329-7470-422C-A546-A762274EFAD8
P2860
Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@en
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@nl
type
label
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@en
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@nl
prefLabel
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@en
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@nl
P2093
P2860
P1476
Olanzapine versus haloperidol ...... double-blind olanzapine trial.
@en
P2093
P2860
P304
P356
10.1046/J.1440-1819.2001.00882.X
P577
2001-08-01T00:00:00Z